Medical news update
- AI-Assisted Point-of-Care Ultrasound Networks
This Viewpoint explores how artificial intelligence–assisted point-of-care ultrasound could be used to create coordinated networks of care to improve health care access and delivery in rural […]
- Effect of Alirocumab in Atherosclerotic Plaques—Reply
In Reply We thank Dimitriadis and colleagues for their interest in our recent work on the lesion-level effects of high-intensity lipid-lowering therapy in the PACMAN-AMI trial. In their Letter to the […]
- OCT vs Angiography for Guidance of Percutaneous Coronary Intervention of Calcified Lesions
This randomized clinical trial determines if optical coherence tomography (OCT) is superior to angiography for calcified lesions percutaneous coronary intervention guidance.
- Finerenone in Heart Failure With Improved Ejection Fraction
This prespecified analysis of a randomized trial examines profiles, risk, and response to finerenone among patients with heart failure with improved ejection fraction compared with patients with left […]
- Effect of Alirocumab in Atherosclerotic Plaques
To the Editor We read with interest the study by Biccirè et al regarding lesion-level effects of low-density lipoprotein cholesterol lowering in patients with acute myocardial infarction (AMI), […]
- Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?
Optimizing detection and treatment of hypertension is one of the greatest public health challenges of our time. More than half of adults have hypertension, with estimates projecting an increase to […]
- Mode of Death in Patients With HFmrEF or HFpEF
This secondary analysis of the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF) randomized clinical trial investigates the […]
- Chest Tube–Induced Right Ventricular Failure After Cardiac Surgery
This case report discusses a diagnosis of right ventricular heart failure secondary to chest tube placement during resternotomy in a male patient aged 73 years.
- Reporting guideline for chatbot health advice studies: the Chatbot Assessment Reporting Tool (CHART) statement
- Reporting guideline for chatbot health advice studies: the Chatbot Assessment Reporting Tool (CHART) statement
- Characteristics, outcomes, and maternity care experiences of women with childrens social care involvement who subsequently died: national cohort study and confidential enquiry
- Characteristics, outcomes, and maternity care experiences of women with childrens social care involvement who subsequently died: national cohort study and confidential enquiry
- Factors predicting outcomes from chronic pain management interventions
- Correction: Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study
- Correction: Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study
- Factors predicting outcomes from chronic pain management interventions
- Epidemiology: a partnership of technical expertise and clinical insight
- Epidemiology: a partnership of technical expertise and clinical insight
- Posts will be published when available. Sorry for inconvenience
- HYPERTENSION
A Common Link Between Cardiovascular, Kidney, and Metabolic Syndrome (HYPE-CKM)
- ESH 2026
INNOVATIONS IN CARDIOMETABOLIC MANAGEMENT
- ESH MASTERplan for Hypertension Management in CKD – webinars
Did you miss the webinar “ESH MASTERplan for Hypertension Management in CKD”? The recording is now available HERE
- Summer School 2025
Date: 14-19 September 2025 Venue: Särö (Gothenburg), Sweden
- NEW ESH 2024 webinars
Webinar 1: Key Points of the Hypertension Guidelines - The ESH MASTERplan for hypertension Webinar 2: Managing Hypertensive Patients in Clinical Practice – Update on the management of […]
- ESH Webinars 2024
PART 1: Updates on resistant hypertension from novel lifestyle interventions to new drugs and interventional therapies PART 2: Hypertension treatment challenges and options in comorbidities
- ESH 2024
BERLIN MAY 31 - JUNE 3, 2024 www.eshannualmeetings.eu Abstracts are available in Journal of Hypertension
- NEW EUROPEAN GUIDELINES
The final version of the full guidelines is now available on the Journal of Hypertension website.
- Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment
The Journal of Clinical Hypertension, Volume 27, Issue 7, July 2025.
- Superselective Adrenal Artery Embolization as a Novel Alternative Treatment for Aldosterone‐Producing Adenomas: A Case of Refractory Hypertension With Concomitant Autonomous Cortisol Secretion
The Journal of Clinical Hypertension, Volume 27, Issue 7, July 2025.
- Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease
The Journal of Clinical Hypertension, Volume 27, Issue 7, July 2025.
- Intensive Blood Pressure Control in Patients With Diabetes and Previous Stroke: A Post‐Hoc Analysis of ACCORD‐BP Trial
The Journal of Clinical Hypertension, Volume 27, Issue 7, July 2025.
- Bring It Down: A Formative Evaluation of Reach and Effectiveness of a Blood Pressure Reduction Program in Detroit, Michigan USA
The Journal of Clinical Hypertension, Volume 27, Issue 7, July 2025.
- Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID‐19 Pandemic
The Journal of Clinical Hypertension, Volume 27, Issue 7, July 2025.
- Clinical and Biochemical Outcomes of Super‐Selective Adrenal Artery Embolization in Primary Aldosteronism: A Systematic Review and Meta‐Analysis
The Journal of Clinical Hypertension, Volume 27, Issue 7, July 2025.
- Hidden Cardiovascular Risk: Arterial Stiffness and Left Ventricular Remodeling as Potential Indicators of Masked Hypertension
The Journal of Clinical Hypertension, Volume 27, Issue 7, July 2025.
- Cerebrovascular reactivity impairment in resistant hypertension
Journal of Human Hypertension, Published online: 02 August 2025; doi:10.1038/s41371-025-01058-wCerebrovascular reactivity impairment in resistant hypertension
- Association between bullous pemphigoid and hypertension: a systematic review and meta-analysis of observational studies
Journal of Human Hypertension, Published online: 29 July 2025; doi:10.1038/s41371-025-01056-yAssociation between bullous pemphigoid and hypertension: a systematic review and meta-analysis of […]
- Exploration of potential therapeutic target genes for preeclampsia through genetic analysis
Journal of Human Hypertension, Published online: 25 July 2025; doi:10.1038/s41371-025-01054-0Exploration of potential therapeutic target genes for preeclampsia through genetic analysis
- Vagal dysfuction in resistant hypertension: no longer the “cinderella” of the autonomic cardiovascular profile
Journal of Human Hypertension, Published online: 25 July 2025; doi:10.1038/s41371-025-01053-1Vagal dysfuction in resistant hypertension: no longer the “cinderella” of the autonomic cardiovascular […]
- Call to action: British and Irish hypertension society position statement on blood pressure treatment thresholds and targets
Journal of Human Hypertension, Published online: 23 July 2025; doi:10.1038/s41371-025-01055-zCall to action: British and Irish hypertension society position statement on blood pressure treatment […]
- Beyond lipid levels: unraveling the hypertensive factor in familial hypercholesterolemia. The HELLAS-FH registry
Journal of Human Hypertension, Published online: 21 July 2025; doi:10.1038/s41371-025-01052-2Beyond lipid levels: unraveling the hypertensive factor in familial hypercholesterolemia. The HELLAS-FH […]
- Independent and joint associations of hypertension and depression with cardiovascular diseases and all-cause mortality: a population-based cohort study
Journal of Human Hypertension, Published online: 17 July 2025; doi:10.1038/s41371-025-01045-1Independent and joint associations of hypertension and depression with cardiovascular diseases and […]
- Age- and sex-specific reference intervals for renin and aldosterone in healthy individuals in Yunnan Province, China
Journal of Human Hypertension, Published online: 16 July 2025; doi:10.1038/s41371-025-01006-8Age- and sex-specific reference intervals for renin and aldosterone in healthy individuals in Yunnan […]
- Which Cardiovascular Risk Calculator Is Best in Older Adults?
PREVENT proved much more accurate than the older calculator in older adults.
- A New Indication for Finerenone, a Mineralocorticoid-Receptor Antagonist
The FDA has approved this drug for treating patients with heart failure and preserved or mildly reduced ejection fraction.
- Should Patients Take Once-Daily Antihypertensive Drugs in the Morning or the Evening?
More evidence shows that when these medications are taken doesn't alter benefits or harms.
- Exercise as Medicine for Preventing Colon Cancer Recurrence
Structured exercise significantly reduces recurrence risk and improves survival for stage II and III colon cancer.
- Intensive Blood Pressure Control: Do the Benefits and Harms Vary with Baseline Cardiovascular Risk?
Although intensive therapy may lead to more adverse events, the benefit-to-harm ratio favors it in patients at all risk levels.
- Lifestyle Modifications in the Treatment of Atrial Fibrillation
Lifestyle modifications are not enough to improve the efficacy of antiarrhythmic drugs; catheter ablation is still superior.
- Shingles Vaccination Probably Protects Against Heart Disease
In a large observational study, risk for cardiovascular disease was 25% lower among vaccinated people.
- Is Routine Defibrillation Testing Necessary for Patients Undergoing Subcutaneous ICD Implantation?
Based on a large, prospective French registry study, the answer is no.